Rof II Llc Orbimed serves as Executive at Xtant Medical Holdings, Inc., where they oversee executive responsibilities. Since joining the company, Rof II Llc Orbimed has executed 8 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 15, 2021 involved transacting 85,337 shares valued at $0.
Rof II Llc Orbimed currently holds 120,549 shares of Xtant Medical Holdings, Inc. (XTNT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rof II Llc Orbimed has been a net neutral trader of XTNT stock. They have purchased $0 and sold $0 worth of shares.
Rof II Llc Orbimed's most recent insider trade was on Aug 15, 2021, when they sold 85,337 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 1, 2020 | XTNT | $12.8M | Award | 11,969,619 | $1.07 | Discretionary |
| Oct 1, 2020 | XTNT | $50.1M | Award | 46,784,775 | $1.07 | Discretionary |
| Feb 5, 2020 | XTNT | $0 | Other | 70,423 | $N/A | Discretionary |
| Feb 5, 2020 | XTNT | $0 | Other | 70,423 | $N/A | Discretionary |
| Oct 30, 2019 | XTNT | $0 | Other | 20,833 | $N/A | Discretionary |
| Oct 30, 2019 | XTNT | $0 | Other | 20,833 | $N/A | Discretionary |